11.07.2015 Views

Winter 2009 - Association of Ontario Midwives

Winter 2009 - Association of Ontario Midwives

Winter 2009 - Association of Ontario Midwives

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Consumer ResourcesHealth Canada to ban BPAThe Government <strong>of</strong> Canadaannounced it will immediatelyproceed with drafting regulations toprohibit the importation, sale andadvertising <strong>of</strong> polycarbonate babybottles that contain bisphenol A (BPA).The Government will also take actionto limit the amount <strong>of</strong> bisphenolA that is being released into theenvironment.“In 2007, we issued a challengeto industry under our ChemicalsManagement Plan to provideinformation on how they managebisphenol A,” said the HonourableTony Clement, Minister <strong>of</strong> Health.“Today’s announcement is a milestonefor our government and for Canada asthe first country in the world to takeregulatory action.”It was determined that the mainsources <strong>of</strong> exposure for newborns andinfants are through the use <strong>of</strong> polycarbonatebaby bottles when they areexposed to high temperatures and themigration <strong>of</strong> bisphenol A from cansinto infant formula.The scientists concluded in thisassessment that bisphenol A exposureto newborns and infants is belowlevels that cause effects; however,due to the uncertainty raised in somestudies relating to the potentialeffects <strong>of</strong> low levels <strong>of</strong> bisphenol A,the Government <strong>of</strong> Canada is takingaction to enhance the protection <strong>of</strong>infants and young children.The Government has allocated anadditional $1.7 million over the nextthree years to fund research projectson bisphenol A. This research, inaddition to major studies currentlyunderway at Health Canada andEnvironment Canada, will help toaddress key knowledge gaps andinform Government decision-makingshould further actions be required.The proposed risk managementapproach will be followed by a 60-dayconsultation period. Regulations areexpected to come into effect in <strong>2009</strong>.For more information, visit theChemicals Management website atwww.chemicalsubstanceschimiques.gc.ca/challenge-defi/bisphenol-a_e.html or call the information line at1-866-891-4542.Cough and cold medicine not for children under sixHealth Canada is requiring manufacturersto relabel over-the-counter cough and coldmedicines with certain active ingredientsto indicate that they should not be used inchildren under 6.Although cough and cold medicines havebeen used by children for many years,there is limited evidence supporting theireffectiveness in this group. In addition,reports <strong>of</strong> misuse, overdose and very rareserious side-effects have raised concernsabout the use <strong>of</strong> these medicines inchildren under 6.The risk to children is only at the time <strong>of</strong>use; in other words, children who usedthese products in the past are not at riskfrom having taken them.Check PregVit vitamins, says Health CanadaHealth Canada is informing expectantmothers and women who are planningpregnancy taking the product PregVitFolic 5 and/or PregVit distributed byDuchesnay Inc. to check the product’s individualsealed packages. Reports relatedto incorrect packaging <strong>of</strong> some blisterpacks have been received by HealthCanada; however no concerns have beenraised regarding the tablets themselves.Individual sealed packages <strong>of</strong> PregVitFolic 5 and PregVit should contain apink blister pack <strong>of</strong> pink tablets to betaken in the morning, and a blue blisterpack <strong>of</strong> blue tablets, to be taken in theevening. The pink and the blue tablets donot contain the same active ingredientsand their daily intake is complementary.Some <strong>of</strong> the individual sealed packages,which should contain both a pink and ablue blister pack, contained only pink orThe relabelling <strong>of</strong> over-the-counter coughand cold medicines will be completed byfall <strong>2009</strong>, in time for the next cough andcold season. Until then, these medicineswill remain on store shelves and in homeswith the current labelling. Labels couldinclude dosing information for childrenunder 6, because many <strong>of</strong> these productsalso have dosing information for adultsand older children on the same label. Forthis cough and cold season, parents orcaregivers should consult a pharmacist ora health care practitioner when buying orusing these products. These medicines canstill be used in children 6 and older, andadults.only blue blister packs. Consumers areadvised to check the individual, sealedpackages to ensure they contain both apink and a blue blister pack so that theyreceive the optimal amount <strong>of</strong> vitaminand mineral supplements.Consumers with the incorrectly packagedproducts are advised to consult theirpharmacist to get a new package.Health Canada has not received anyadverse reaction reports related to themis-packaging <strong>of</strong> these products inCanada. Preventive benefits, as well asvitamin and mineral supplementationwill be optimized by using correctly packagedproducts.Consumers requiring more informationabout this advisory can contact HealthCanada’s public enquiries line at (613)957-2991, or toll free at 1-866-225-0709.10ontario midwife • <strong>Winter</strong> <strong>2009</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!